CSC
AVNS

Cove Street Capital’s Avanos Medical AVNS Stock Holding History

Cove Street Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.3M Buy
112,081
+90,963
+431% +$1.07M 1.69% 25
2025
Q2 		$258K Sell
21,118
-1,078
-5% -$13.6K 0.38% 50
2025
Q1 		$318K Buy
+22,196
New +$347K 0.5% 40
2021
Q4 		– Sell
-6,648
Closed -$207K – 90
2021
Q3 		$207K Buy
+6,648
New +$226K 0.03% 72
2021
Q1 		– Sell
-204,438
Closed -$9.38M – 87
2020
Q4 		$9.38M Sell
204,438
-196,251
-49% -$8.17M 1.66% 25
2020
Q3 		$13.3M Sell
400,689
-50,127
-11% -$1.6M 2.52% 13
2020
Q2 		$13.3M Sell
450,816
-360,620
-44% -$10.4M 2.62% 11
2020
Q1 		$21.9M Buy
811,436
+555,933
+218% +$16.6M 4.48% 6
2019
Q4 		$8.61M Buy
255,503
+196,651
+334% +$7.12M 1.14% 34
2019
Q3 		$2.21M Buy
+58,852
New +$2.25M 0.31% 48
2018
Q1 		– Sell
-359,465
Closed -$16.6M – 109
2017
Q4 		$16.6M Sell
359,465
-8,365
-2% -$384K 1.79% 21
2017
Q3 		$16.6M Sell
367,830
-14,485
-4% -$618K 1.85% 18
2017
Q2 		$15M Sell
382,315
-141,000
-27% -$5.33M 1.82% 22
2017
Q1 		$19.9M Sell
523,315
-143,655
-22% -$5.6M 2.11% 20
2016
Q4 		$24.7M Sell
666,970
-75,883
-10% -$2.71M 2.58% 11
2016
Q3 		$25.7M Sell
742,853
-73,955
-9% -$2.59M 2.78% 11
2016
Q2 		$26.6M Buy
816,808
+308,600
+61% +$9.45M 2.93% 9
2016
Q1 		$14.6M Buy
508,208
+169,875
+50% +$4.53M 1.91% 19
2015
Q4 		$11.3M Sell
338,333
-34,215
-9% -$1.06M 1.49% 30
2015
Q3 		$10.6M Buy
372,548
+109,182
+41% +$3.81M 1.4% 27
2015
Q2 		$10.7M Buy
263,366
+30,800
+13% +$1.38M 1.29% 34
2015
Q1 		$11.4M Sell
232,566
-23,689
-9% -$1.1M 1.5% 29
2014
Q4 		$11.7M Buy
+256,255
New +$10.1M 1.74% 25

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cove Street Capital's AVNS Position: Q3 2025 in Review

Cove Street Capital increased its Avanos Medical (AVNS) stake by 431% in Q3 2025, buying an estimated $1.07M and bringing the position to 112,081 shares worth $1.3M. The position accounts for 1.69% of the portfolio, ranked #25.

Cove Street Capital first reported a position in AVNS in Q4 2014 and has held it in 23 quarters since. The position peaked at $26.6M in Q2 2016. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Cove Street Capital held 112,081 shares of Avanos Medical worth $1.3M as of Q3 2025.
  • Cove Street Capital bought 90,963 Avanos Medical shares in Q3 2025, an estimated $1.07M.
  • Avanos Medical made up 1.69% of Cove Street Capital's portfolio in Q3 2025, its #25 holding.
  • Cove Street Capital first reported a position in Avanos Medical in Q4 2014 and has held it in 23 quarters since.
  • Cove Street Capital's Avanos Medical position peaked at $26.6M in Q2 2016.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Cove Street Capital's 13F filing for Q3 2025, filed 13 Nov 2025.